BACK TO LISTINGS

Cystic Fibrosis Canada’s 2023 Annual General Meeting

preparing for a virtual meeting, laptop and coffee

News

MAY 26, 2023

Cystic Fibrosis Canada held its Annual General Meeting on Friday, April 28, 2023. The executive team, board of directors and members joined to reflect on the previous year as well as review our financial report. Cystic Fibrosis Canada’s financial report can be found in the 2022-2023 Impact Report.

Watch Kelly Grover, President and CEO, Cystic Fibrosis Canada and Leona Pinsky, Board Chair, present their remarks to AGM attendees.

Cystic Fibrosis Canada’s President and CEO, Kelly Grover, delivers her remarks at the 2023 Annual General Meeting

Leona Pinsky, Board Chair, Cystic Fibrosis Canada, delivers her remarks at the 2023 AGM

DECEMBER 4, 2023

News

Shinerama Shines On: Celebrating 59 Years of Sparkling Success in Student Fundraising

Thousands of post-secondary students across Canada banded together this Shinetember to raise essential funds for cystic fibrosis research, care and advocacy. Shinerama is Canada’s largest post-secondary fundraising event for cystic...

NOVEMBER 30, 2023

News

Health Canada approval signals shift in CF treatment for newborns

Health Canada has approved the cystic fibrosis drug Kalydeco (Ivacaftor) for children aged 2-4 months old who have one of the following mutations in the CFTR gene: G551D, G1244E, G1349D,...

NOVEMBER 24, 2023

News Research

NACFC 2023: Cystic fibrosis is in a state of change

In early November, Cystic Fibrosis Canada team members attended the annual North American Cystic Fibrosis Conference (NACFC) in Phoenix, Arizona, participating in focused discussions, presentations, and plenaries that shed light...

Cystic Fibrosis Canada’s 2023 Annual General Meeting

Related Posts

Shinerama Shines On: Celebrating 59 Years of Sparkling Success in Student Fundraising

Health Canada approval signals shift in CF treatment for newborns

NACFC 2023: Cystic fibrosis is in a state of change